drug development

This Startup Just Raised $123 Million To Develop A New Way To Find Medicine
This Startup Just Raised $123 Million To Develop A New Way To Find Medicine
Forbes
Cellarity
startups
drug discovery
drug development
Flag link:
UCB taps Microsoft to accelerate drug discovery, clinical trials
UCB taps Microsoft to accelerate drug discovery, clinical trials
Fierce Biotech
UCB Pharma
Microsoft
drug development
drug discovery
artificial intelligence
Flag link:
Evox has big pharma partners. Now it has $95M to bring its own drugs to the clinic
Evox has big pharma partners. Now it has $95M to bring its own drugs to the clinic
MedCity News
Evox Therapeutics
exosomes
drug development
Flag link:
Pharma’s ambitious new antibiotic venture hires a CEO to fix a ‘broken’ pipeline
Pharma’s ambitious new antibiotic venture hires a CEO to fix a ‘broken’ pipeline
Stat
antibiotics
drug development
antibiotic resistance
AMR Action Fund
Henry Skinner
Flag link:
On the hunt for a better antibody, BigHat Biosciences debuts with $19M Series A to scale its 'wet lab' AI platform
On the hunt for a better antibody, BigHat Biosciences debuts with $19M Series A to scale its 'wet lab' AI platform
Endpoints
BigHat Biosciences
artificial intelligence
machine learning
drug development
antibodies
Flag link:
Drug Farm bags $56M to take novel hepatitis B drug into humans
Drug Farm bags $56M to take novel hepatitis B drug into humans
Fierce Biotech
Drug Farm
hepatitis B
funding
drug development
Flag link:
Sanofi flunks Parkinson's Phase II, axes handful of mid-stage programs in Q4 earnings
Sanofi flunks Parkinson's Phase II, axes handful of mid-stage programs in Q4 earnings
Endpoints
Sanofi
earnings
Parkinson's Disease
drug development
Flag link:
Pfizer bags rheumatoid arthritis rights to new immunotherapy class through deal with Imcyse
Pfizer bags rheumatoid arthritis rights to new immunotherapy class through deal with Imcyse
Fierce Biotech
Pfizer
Imcyse
rheumatoid arthritis
drug development
Flag link:
Roche chucks out phase 3 ipatasertib combo tests, midstage IL-33 asthma, BTKi arthritis trials in Q4 clear-out
Roche chucks out phase 3 ipatasertib combo tests, midstage IL-33 asthma, BTKi arthritis trials in Q4 clear-out
Fierce Biotech
Roche
earnings
cancer
autoimmune disease
drug development
Flag link:
GSK culls cancer, rare disease meds amid Q4 clear-out
GSK culls cancer, rare disease meds amid Q4 clear-out
Fierce Biotech
GSK
earnings
R&D
drug development
Flag link:
Amgen slams the brakes on a clutch of cancer drugs as reality BiTEs
Amgen slams the brakes on a clutch of cancer drugs as reality BiTEs
Fierce Biotech
Amgen
earnings
cancer
oncology
drug development
Flag link:
Gilead partners with a cancer biotech, seeking to develop an HIV immunotherapy
Gilead partners with a cancer biotech, seeking to develop an HIV immunotherapy
BioPharma Dive
Gilead Sciences
HIV
Gritstone Oncology
drug development
Flag link:
AstraZeneca scores new goal on the pipeline front, adding its first AI-generated target to the portfolio
AstraZeneca scores new goal on the pipeline front, adding its first AI-generated target to the portfolio
Endpoints
AstraZeneca
artificial intelligence
drug development
Flag link:
Five Technologies That Will Transform Medicine In Post-Pandemic America
Five Technologies That Will Transform Medicine In Post-Pandemic America
Forbes
telemedicine
data
data analytics
drug development
artificial intelligence
patients
Flag link:
180 Life Sciences Poised to Break Ground with Anti-TNF Program
180 Life Sciences Poised to Break Ground with Anti-TNF Program
BioSpace
anti-TNF
drug development
Flag link:
BeiGene, Novartis in pact to develop tislelizumab for cancer settings
BeiGene, Novartis in pact to develop tislelizumab for cancer settings
Seeking Alpha
Novartis
BeiGene
tiselizumab
cancer
drug development
Flag link:
What if we captured the spirit and urgency of Covid-19 research to cure cancer?
What if we captured the spirit and urgency of Covid-19 research to cure cancer?
MedCity News
COVID-19
R&D
drug development
cancer
oncology
Flag link:
AI offers promise but faces barriers in drug development
AI offers promise but faces barriers in drug development
MedCity News
artificial intelligence
drug development
Flag link:
Better Together – Merck KGaA Announces Collaboration with Artios
Better Together – Merck KGaA Announces Collaboration with Artios
BioSpace
Merck KGaA
Artios Pharma
drug development
cancer
oncology
Flag link:
AbbVie pays Frontier $55M to pursue hard-to-drug targets
AbbVie pays Frontier $55M to pursue hard-to-drug targets
Fierce Biotech
AbbVie
Frontier Medicines
drug development
Flag link:

Pages